Cedar Brook Financial Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,958
| Closed | -$387K | – | 287 |
|
|
2024
Q1 | $387K | Sell |
13,958
-710
| -5% | -$19.7K | 0.08% | 259 |
|
|
2023
Q4 | $417K | Sell |
14,668
-1,453
| -9% | -$41.3K | 0.09% | 221 |
|
|
2023
Q3 | $535K | Sell |
16,121
-3,772
| -19% | -$125K | 0.14% | 161 |
|
|
2023
Q2 | $730K | Sell |
19,893
-2,015
| -9% | -$73.9K | 0.17% | 132 |
|
|
2023
Q1 | $894K | Buy |
21,908
+1,431
| +7% | +$58.4K | 0.23% | 112 |
|
|
2022
Q4 | $1.05M | Buy |
20,477
+1,331
| +7% | +$68.2K | 0.3% | 91 |
|
|
2022
Q3 | $838K | Buy |
19,146
+676
| +4% | +$29.6K | 0.27% | 97 |
|
|
2022
Q2 | $968K | Sell |
18,470
-888
| -5% | -$46.5K | 0.3% | 88 |
|
|
2022
Q1 | $1M | Buy |
19,358
+661
| +4% | +$34.2K | 0.26% | 93 |
|
|
2021
Q4 | $1.1M | Buy |
18,697
+5,268
| +39% | +$311K | 0.28% | 86 |
|
|
2021
Q3 | $578K | Sell |
13,429
-1,645
| -11% | -$70.8K | 0.17% | 147 |
|
|
2021
Q2 | $590K | Buy |
15,074
+2,738
| +22% | +$107K | 0.17% | 149 |
|
|
2021
Q1 | $447K | Sell |
12,336
-5,072
| -29% | -$184K | 0.15% | 157 |
|
|
2020
Q4 | $641K | Buy |
17,408
+826
| +5% | +$30.4K | 0.23% | 113 |
|
|
2020
Q3 | $577K | Buy |
16,582
+3,048
| +23% | +$106K | 0.23% | 122 |
|
|
2020
Q2 | $420K | Buy |
13,534
+206
| +2% | +$6.39K | 0.19% | 147 |
|
|
2020
Q1 | $413K | Buy |
13,328
+2,695
| +25% | +$83.5K | 0.23% | 129 |
|
|
2019
Q4 | $395K | Sell |
10,633
-2,499
| -19% | -$92.8K | 0.17% | 163 |
|
|
2019
Q3 | $448K | Sell |
13,132
-1,812
| -12% | -$61.8K | 0.2% | 154 |
|
|
2019
Q2 | $614K | Buy |
14,944
+358
| +2% | +$14.7K | 0.28% | 115 |
|
|
2019
Q1 | $588K | Buy |
14,586
+319
| +2% | +$12.9K | 0.29% | 108 |
|
|
2018
Q4 | $591K | Buy |
+14,267
| New | +$591K | 0.36% | 88 |
|